Brandes Investment Partners LP Has $5.98 Million Holdings in DENTSPLY SIRONA Inc. $XRAY

Brandes Investment Partners LP grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 257.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 376,662 shares of the medical instruments supplier’s stock after acquiring an additional 271,221 shares during the quarter. Brandes Investment Partners LP owned 0.19% of DENTSPLY SIRONA worth $5,981,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in XRAY. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after purchasing an additional 557,329 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after buying an additional 1,412,517 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 4.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after buying an additional 538,531 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of DENTSPLY SIRONA by 119.4% in the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after acquiring an additional 3,453,662 shares during the last quarter. Finally, Edmond DE Rothschild Holding S.A. boosted its holdings in shares of DENTSPLY SIRONA by 6.0% during the 2nd quarter. Edmond DE Rothschild Holding S.A. now owns 3,087,300 shares of the medical instruments supplier’s stock valued at $49,026,000 after acquiring an additional 173,900 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $11.11 on Wednesday. The company has a market cap of $2.22 billion, a P/E ratio of -2.34, a PEG ratio of 0.81 and a beta of 1.01. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The business has a 50-day moving average price of $11.98 and a two-hundred day moving average price of $14.00. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Mizuho set a $13.00 price objective on DENTSPLY SIRONA in a research note on Friday, November 7th. JPMorgan Chase & Co. dropped their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Finally, UBS Group dropped their price target on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research note on Tuesday, October 28th. Two equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $16.08.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.